These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

877 related items for PubMed ID: 17666600

  • 1. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
    Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A.
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):267-78. PubMed ID: 17666600
    [Abstract] [Full Text] [Related]

  • 2. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT.
    Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
    [Abstract] [Full Text] [Related]

  • 3. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial.
    Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R.
    Am J Obstet Gynecol; 2008 Oct; 199(4):435.e1-7. PubMed ID: 18928998
    [Abstract] [Full Text] [Related]

  • 4. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
    Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C.
    Am J Gastroenterol; 2008 May; 103(5):1182-92. PubMed ID: 18371137
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR.
    Arzneimittelforschung; 2010 May; 60(6a):386-98. PubMed ID: 20648930
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N, Russell R.
    BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
    [Abstract] [Full Text] [Related]

  • 11. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O, Richard-Davis G, Morris T, Armstrong J.
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [Abstract] [Full Text] [Related]

  • 12. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
    Kim YH, Chung HH, Kang SB, Kim SC, Kim YT.
    Acta Haematol; 2009 Aug; 121(1):37-41. PubMed ID: 19332985
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia.
    Pfenniger A, Schuller C, Christoph P, Surbek D.
    J Perinat Med; 2012 Apr 02; 40(4):397-402. PubMed ID: 22752771
    [Abstract] [Full Text] [Related]

  • 14. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators.
    N Engl J Med; 2009 Dec 17; 361(25):2436-48. PubMed ID: 19920054
    [Abstract] [Full Text] [Related]

  • 15. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.
    Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G.
    J Matern Fetal Neonatal Med; 2013 May 17; 26(7):654-9. PubMed ID: 23130909
    [Abstract] [Full Text] [Related]

  • 16. Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate to severe postpartum anaemia in Nigerian women (IVON-PP): protocol for an open-label randomised controlled type 1 hybrid effectiveness-implementation trial.
    Afolabi BB, Adaramoye VO, Adeyemo TA, Balogun M, Mitchell EJ, Walker K, Akinajo OR, Abioye IA, Banke-Thomas A, Babah OA, Chieme CF, Oshodi Y, Quao R, Eboreime EA, Ogunsola F.
    BMJ Open; 2024 Aug 17; 14(8):e086553. PubMed ID: 39153791
    [Abstract] [Full Text] [Related]

  • 17. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
    Bisbe E, Moltó L, Arroyo R, Muniesa JM, Tejero M.
    Br J Anaesth; 2014 Sep 17; 113(3):402-9. PubMed ID: 24780615
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana - An interventional study.
    Kant S, Kaur R, Ahamed F, Singh A, Malhotra S, Kumar R.
    Indian J Public Health; 2020 Sep 17; 64(2):168-172. PubMed ID: 32584300
    [Abstract] [Full Text] [Related]

  • 19. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
    Beigel F, Löhr B, Laubender RP, Tillack C, Schnitzler F, Breiteneicher S, Weidinger M, Göke B, Seiderer J, Ochsenkühn T, Brand S.
    Digestion; 2012 Sep 17; 85(1):47-54. PubMed ID: 22179489
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia.
    Breymann C, Gliga F, Bejenariu C, Strizhova N.
    Int J Gynaecol Obstet; 2008 Apr 17; 101(1):67-73. PubMed ID: 18234203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.